GlassScriptPhysician profile
William Benjamin White
NPI 1942650056
$51,283.00
in general payments reported to CMS, 2019-2025
28 companies · $8,823 in 2025
The $8,823 reported for 2025 was more than what 78% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $208 · 2021: $566 · 2022: $9,696 · 2023: $17K · 2024: $14K · 2025: $8,823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Food and Beverage: $10K · Grant: $9,168 · Consulting Fee: $4,878 · Education: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,812.10 |
| Food and Beverage | $10,409.46 |
| Grant | $9,167.98 |
| Consulting Fee | $4,878.00 |
| Education | $211.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $28,424.35 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $6,069.34 | 2022-2025 | Ensite Precision, Ensite, Aveir |
| Philips North America LLC | $5,704.49 | 2024 | (9520) Igt Devices Undivided, (6554) Peripheral Vascular Undivided, (Bh4) Igt Devices Undivided |
| Sanofi US Services INC. | $4,878.00 | 2025 | |
| Boston Scientific Corporation | $2,915.08 | 2023-2025 | Versacross Access Solution, Rhythmia Mapping System, General - Therapies |
| Biosense Webster, INC. | $1,089.37 | 2021-2025 | Carto 3, Qdot Micro Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $460.94 | 2020-2025 | Lifevest |
| Abiomed | $305.03 | 2020-2025 | Impella |
| Medtronic Vascular, INC. | $290.77 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $263.41 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $142.78 | 2024 | Optimizer |
| Stryker Corporation | $125.83 | 2025 | Flowtriever |
| Astrazeneca Pharmaceuticals LP | $115.57 | 2021 | |
| Janssen Pharmaceuticals, INC | $93.06 | 2020-2024 | Xarelto |
| Stereotaxis INC | $59.66 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $55.35 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiva Medical, INC. | $42.10 | 2021 | |
| Atricure, INC. | $41.69 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Pfizer INC. | $32.65 | 2021 | |
| Asahi Intecc USA, INC. | $29.87 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $24.67 | 2019 | |
| Acist Medical Systems, INC. | $24.18 | 2024 | |
| Vital Connect, INC | $17.67 | 2025 | Vitalpatch Rtm |
| Amgen INC. | $17.41 | 2022 | |
| Getinge USA Sales, LLC | $15.85 | 2020 | |
| Terumo Medical Corporation | $15.11 | 2019 | |
| Shockwave Medical, INC | $14.99 | 2020 | |
| Cleerly, INC. | $13.78 | 2023 | Cleerly Labs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.